Optimizating The Expression Of A Recombinant Anti-CD20 IgG For The Treatment Of Canine Lymphoma

Immunology and Microbiology

1. Monoclonal Antibodies 100%
2. Light Chain 100%
3. Hydrogen/Deuterium Exchange Mass Spectrometry 100%
4. Binding Antibody 100%
5. Paratope 100%
6. Hybridoma 37%
7. Cells 25%
8. Time 25%
9. Length 25%
10. CD20 25%
11. Antigen 12%
12. Development 12%
13. Rituximab 12%
14. Mass Spectrometry 12%
15. B Cell 12%
16. CD20 Antibody 12%
17. Monospecific Antibody 12%